The Effect of Intermittent Rifampicin on Raltegravir

NCT01424826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

HIV
Tuberculosis

Interventions

DRUG: Raltegravir
DRUG: Rifampicin
DRUG: Raltegravir

Sponsor

Helen Reynolds

Collaborators

[object Object]